X-Chem

3d structure of the protein molecule
#Collaboration #Genetics / genomics #Partnership #Proteomics #Structural Genomics Consortium #X-Chem

Partners collaborate to unlock the human proteome

X-Chem and the Structural Genomics Consortium (SGC) have entered a collaboration aimed at creating new chemical tools to study human proteins. The goal is to generate DNA-encoded library (DEL) screening data for large numbers of under-addressed proteins in the human proteome – ultimately allowing drug discovery and machine learning (ML)… Read More

#Business & Investment #News

Protein degradation
#Collaboration #DNA #Kymera Therapeutics #Library screening #Partnership #Protein chemistry / Proteomics #X-Chem

X-Chem and Kymera expand partnership to 12 targets

X-Chem and Kymera Therapeutics have expanded their collaboration, which will now comprise 12 targets and grants Kymera exclusive rights to compounds discovered within the collaboration.   With the expanded agreement, X-Chem will serve as the primary provider of DNA-encoded library (DEL)-based screening services to Kymera – using its DEL platform to… Read More

#Business & Investment #News

Neurons in Parkinson's disease
#Biologics / Biotechnology #Collaboration #Drug discovery #Library screening #Neurodegenerative disorders #Partnership #Sironax #X-Chem

Research partners will target neurodegenerative disease

X-Chem and Sironax have agreed a research partnership, in which X-Chem will use its DEL platform to support Sironax’s drug discovery pipeline.   Through the collaboration, X-Chem will screen its DNA-encoded libraries (DEL) against difficult-to-drug targets implicated in neurodegenerative disease to discover hits. In turn, Sironax will prosecute these hits into… Read More

#Business & Investment #News